PAM
BMY.RT

Panagora Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Panagora Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,744
Closed -$9K – 3127
2020
Q4 		$9K Sell
13,744
-4,306
-24% -$9.17K ﹤0.01% 2324
2020
Q3 		$41K Sell
18,050
-1,423
-7% -$4.06K ﹤0.01% 2068
2020
Q2 		$70K Hold
19,473
– – ﹤0.01% 1904
2020
Q1 		$74K Sell
19,473
-17,585
-47% -$57.9K ﹤0.01% 1787
2019
Q4 		$112K Buy
+37,058
New +$96.4K ﹤0.01% 1775

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Panagora Asset Management's BMY.RT Position: Q1 2021 in Review

Panagora Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 13,744 shares — an estimated $9K sold.

Panagora Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $112K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Panagora Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 13,744 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9K.
  • Panagora Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Panagora Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $112K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.